Partial immunity and SARS-CoV-2 mutations-Response

Chadi M Saad-Roy¹, Sinead E Morris², C Jessica E Metcalf^{3

4}, Michael J Mina⁵, Rachel E Baker^{3

6}, Jeremy Farrar⁷, Edward C Holmes⁸, Oliver G Pybus⁹, Andrea L Graham³, Simon A Levin³, Bryan T Grenfell^{10

4

11}, Caroline E Wagner¹²

Affiliations

¹ Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.
² Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.
³ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
⁴ Princeton School of Public and International Affairs, Princeton University, Princeton, NJ 08544, USA.
⁵ Departments of Epidemiology and Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
⁶ High Meadows Environmental Institute, Princeton University, Princeton, NJ 08544, USA.
⁷ The Wellcome Trust, London NW1 2BE, UK.
⁸ Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences, and School of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
⁹ Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.
¹⁰ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.
¹¹ Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.
¹² Department of Bioengineering, McGill University, Montreal, QC H3A 0C3, Canada. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.

Comment

Chadi M Saad-Roy et al. Science. 2021.

. 2021 Apr 23;372(6540):354-355.

doi: 10.1126/science.abi6719.

¹ Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.
² Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA.
³ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
⁴ Princeton School of Public and International Affairs, Princeton University, Princeton, NJ 08544, USA.
⁵ Departments of Epidemiology and Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
⁶ High Meadows Environmental Institute, Princeton University, Princeton, NJ 08544, USA.
⁷ The Wellcome Trust, London NW1 2BE, UK.
⁸ Marie Bashir Institute for Infectious Diseases and Biosecurity, School of Life and Environmental Sciences, and School of Medical Sciences, The University of Sydney, Sydney, NSW 2006, Australia.
⁹ Department of Zoology, University of Oxford, Oxford OX1 3SZ, UK.
¹⁰ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.
¹¹ Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA.
¹² Department of Bioengineering, McGill University, Montreal, QC H3A 0C3, Canada. csaadroy@princeton.edu grenfell@princeton.edu caroline.wagner@mcgill.ca.

No abstract available

Comment on

Partial immunity and SARS-CoV-2 mutations.
Hanage WP, Russell CA. Hanage WP, et al. Science. 2021 Apr 23;372(6540):354. doi: 10.1126/science.abi4727. Science. 2021. PMID: 33888632 No abstract available.